Education
About Us
Working with TipRanks
Follow Us
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 55.25M | $ 682.00K | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 47.28M | $ 515.00K | $ -620.00K | $ -521.00K | $ -300.00K |
| Operating Income | $ -277.47M | $ -167.31M | $ -172.44M | $ -135.08M | $ -125.67M |
| EBITDA | $ -261.52M | $ -159.05M | $ -169.80M | $ -136.57M | $ -124.19M |
| Net Income | $ -334.33M | $ -201.59M | $ -197.72M | $ -143.88M | $ -129.07M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 297.26M | $ 381.39M | $ 155.38M | $ 183.26M | $ 287.50M |
| Total Assets | $ 378.32M | $ 413.84M | $ 164.81M | $ 189.43M | $ 295.11M |
| Total Debt | $ 554.95M | $ 139.03M | $ 97.07M | $ 91.34M | $ 49.02M |
| Net Debt | $ 257.68M | $ -242.36M | $ -58.31M | $ -91.92M | $ -238.48M |
| Total Liabilities | $ 631.90M | $ 486.60M | $ 239.62M | $ 117.28M | $ 100.84M |
| Stockholders' Equity | $ -253.58M | $ -72.76M | $ -74.81M | $ 72.16M | $ 194.27M |
| Cash Flow | |||||
| Free Cash Flow | $ -266.90M | $ -139.21M | $ -147.57M | $ -148.78M | $ -70.73M |
| Operating Cash Flow | $ -266.77M | $ -137.58M | $ -146.53M | $ -148.46M | $ -69.69M |
| Investing Cash Flow | $ -135.00K | $ -1.63M | $ -1.04M | $ -328.00K | $ -1.04M |
| Financing Cash Flow | $ 182.77M | $ 367.58M | $ 120.04M | $ 44.71M | $ 114.46M |